The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-4-(3,4-dichlorophenyl)-N-(4-(trifluoromethyl)benzyl)butan-2-amine ID: ALA4869437
PubChem CID: 52516003
Max Phase: Preclinical
Molecular Formula: C18H18Cl2F3N
Molecular Weight: 376.25
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](CCc1ccc(Cl)c(Cl)c1)NCc1ccc(C(F)(F)F)cc1
Standard InChI: InChI=1S/C18H18Cl2F3N/c1-12(2-3-13-6-9-16(19)17(20)10-13)24-11-14-4-7-15(8-5-14)18(21,22)23/h4-10,12,24H,2-3,11H2,1H3/t12-/m0/s1
Standard InChI Key: GGJQHRVUXPWESE-LBPRGKRZSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
26.5614 -3.0252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5603 -3.8448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2683 -4.2537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9780 -3.8443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9752 -3.0216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2665 -2.6164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6863 -4.2518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3934 -3.8421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1018 -4.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8088 -3.8398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5172 -4.2473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2242 -3.8376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1030 -5.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9298 -4.2453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6363 -3.8363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6355 -3.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9222 -2.6109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2185 -3.0223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3420 -2.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0509 -3.0141 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.3396 -1.7904 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.0443 -2.1916 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.8536 -2.6168 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
25.8523 -4.2528 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
9 13 1 1
12 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 12 1 0
16 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
1 23 1 0
2 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.25Molecular Weight (Monoisotopic): 375.0768AlogP: 6.12#Rotatable Bonds: 6Polar Surface Area: 12.03Molecular Species: BASEHBA: 1HBD: 1#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 9.60CX LogP: 6.49CX LogD: 4.33Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.64Np Likeness Score: -1.14
References 1. Rishton GM, Look GC, Ni ZJ, Zhang J, Wang Y, Huang Y, Wu X, Izzo NJ, LaBarbera KM, Limegrover CS, Rehak C, Yurko R, Catalano SM.. (2021) Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease., 12 (9.0): [PMID:34531947 ] [10.1021/acsmedchemlett.1c00048 ]